Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus
- PMID: 3292793
- PMCID: PMC253749
- DOI: 10.1128/JVI.62.8.3053-3058.1988
Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus
Abstract
We have purified a 10,774-dalton protein from human immunodeficiency virus (HIV) type 1 that is encoded in the protease domain of the pol open reading frame (ORF). Radiochemical amino acid microsequencing identified 12 amino acids from the stretch of 39 N-terminal residues of this protein, beginning with a PQITLW sequence at position 69 of the pol ORF. Radiosequencing of selected tryptic peptides of the protein identified 11 additional residues (Leu-9 and Val-2) in six peptides encompassing the entire molecule of 99 residues. A protein of similar size and identical N-terminal sequence (determined through the first 39 residues) was present among the processed HIV pol gene products in Escherichia coli which expressed the entire HIV pol ORF. The C terminus of both the viral and E. coli-expressed proteins was inferred to be contiguous with the N terminus of the p64-p51 reverse transcriptase on the basis of tryptic mapping and specific immunoreactivity with an antiserum against a dodecapeptide located upstream of the reverse transcriptase. Thus, the initial processing of the pol precursor that generates the native protease is apparently preserved across phylogenetic barriers. Although the purified viral protease lacked measurable proteolytic activity, the bacterial extracts were capable of processing an HIV gag precursor protein synthesized in E. coli.
Similar articles
-
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.Proc Natl Acad Sci U S A. 1987 Dec;84(24):8903-6. doi: 10.1073/pnas.84.24.8903. Proc Natl Acad Sci U S A. 1987. PMID: 3321060 Free PMC article.
-
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.J Biol Chem. 1990 Aug 15;265(23):13890-8. J Biol Chem. 1990. PMID: 2199446
-
Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.Virology. 1988 Oct;166(2):339-49. doi: 10.1016/0042-6822(88)90504-1. Virology. 1988. PMID: 2459842
-
Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.Princess Takamatsu Symp. 1984;15:147-57. Princess Takamatsu Symp. 1984. PMID: 6100635 Review.
-
HIV-1 replication.Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. doi: 10.1023/a:1021070512287. Somat Cell Mol Genet. 2001. PMID: 12465460 Review.
Cited by
-
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6644-8. doi: 10.1073/pnas.87.17.6644. Proc Natl Acad Sci U S A. 1990. PMID: 2204060 Free PMC article.
-
Immunological characterization of the gag gene products of bovine immunodeficiency virus.J Virol. 1992 Dec;66(12):6868-77. doi: 10.1128/JVI.66.12.6868-6877.1992. J Virol. 1992. PMID: 1331499 Free PMC article.
-
Resistance to human immunodeficiency virus type 1 protease inhibitors.Antimicrob Agents Chemother. 1998 Nov;42(11):2775-83. doi: 10.1128/AAC.42.11.2775. Antimicrob Agents Chemother. 1998. PMID: 9797203 Free PMC article. Review. No abstract available.
-
Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.Antimicrob Agents Chemother. 1999 Feb;43(2):253-8. doi: 10.1128/AAC.43.2.253. Antimicrob Agents Chemother. 1999. PMID: 9925514 Free PMC article.
-
A fission yeast cell-based system for multidrug resistant HIV-1 proteases.Cell Biosci. 2017 Jan 11;7:5. doi: 10.1186/s13578-016-0131-5. eCollection 2017. Cell Biosci. 2017. PMID: 28096973 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources